Dr. Soumerai has published more than 250 original scientific articles in leading scientific journals, such as the New England Journal of Medicine and the Journal of the American Medical Association. He is well known nationally and internationally for his work on the impacts of health policies and methods to improve the quality of medical practice. His recent research has focused on cost-related underuse of medications; as well as the impacts of drug coverage and cost-containment policies on access to effective medications, quality and costs of care and clinical outcomes among vulnerable populations, and the unintended health outcomes of FDA warnings regarding use of antidepressants in adolescents. He frequently advises Congress, state legislatures, and federal and international agencies on the design of drug cost containment, coverage and quality-of-care policies, and evidence-based health policy. His research has been used extensively to support expanded economic access to medications in Medicaid and Medicare.
Dr. Soumerai has published numerous op-eds in leading news outlets, including The Wall Street Journal, Vox, The Washington Post, Newsweek, The Huffington Post, The Boston Globe and the Health Affairs Blog on subjects including elimination of coverage gaps in the Medicare drug benefit, adverse consequences of rushed nationwide implementation of health IT, undertreatment of pain, drug coverage in Massachusetts health reform plans, state censorship of health research, poor efficacy of pay-for-performance policies, and arbitrary economic penalties for hospital readmissions.
Dr. Soumerai's methodological work focuses on demonstrating bias in research designs, improving the evidence base for health policies, and "flip flopping" health research.